Direction des risques biologiques et de la santé au travail, Institut National de Santé Publique du Québec, Québec, Canada.
Axe Maladies infectieuses et immunitaires, Centre de Recherche du CHU de Québec - Université Laval, Québec, Canada.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2028516. doi: 10.1080/21645515.2022.2028516. Epub 2022 Feb 1.
The Pfizer-BioNTech COVID-19 vaccine was recently authorized for Canadian children aged 5 to 11 years old. Previous studies have indicated that low parental vaccination intention can be anticipated. To better understand drivers of vaccine hesitancy among parents of 5-11 years old children, four focus group discussions were conducted. Interviewed parents generally showed little concern about the risk of COVID-19 for their child(ren) and many mentioned that children are at low risk of complications from COVID-19. Out of 28 participants, seven intended to vaccinate their child(ren) while the remaining were unsure or unwilling. Even if parents were themselves vaccinated, many hesitated for their child(ren). These parents perceived that it was unnecessary (due to low risk of complications) and were concerned about risks of side effects. Clear communication on vaccine safety and usefulness will be critical to reassure parents and foster vaccine acceptance.
辉瑞-BioNTech COVID-19 疫苗最近在加拿大获得批准，可用于 5 至 11 岁儿童。先前的研究表明，预计家长对接种疫苗的意愿较低。为了更好地了解 5-11 岁儿童家长对接种疫苗犹豫不决的原因，进行了四次焦点小组讨论。接受采访的家长普遍对孩子感染 COVID-19 的风险不太关注，许多人提到孩子患 COVID-19 并发症的风险较低。在 28 名参与者中，有 7 人打算为孩子接种疫苗，而其余的人则不确定或不愿意。即使父母自己接种了疫苗，许多父母对接种孩子疫苗仍犹豫不决。这些家长认为接种疫苗是不必要的（因为并发症的风险较低），并且担心副作用的风险。就疫苗的安全性和有效性进行清晰的沟通对于让家长放心并促进疫苗接种至关重要。
